SRPT | Value the Markets

Company Overview

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a rare genetic disorder affecting children. The company received accelerated approval for Exondys 51, Amondys 45 (casimersen) and Vyondys 53 (golodirsen). Exondys 51 is Sarepta's first PMO-based technology to be granted accelerated approval by the FDA. The company is conducting a confirmatory study on the clinical benefits of these drugs for gaining continued approval. The rest of its exon-skipping DMD pipeline includes a PPMO-based, exon 51 skipping candidate, SRP-5051. Sarepta is also developing gene therapies for treating DMD, Limb-girdle muscular dystrophy and central nervous system disorders including Mucopolysaccharidosis type IIIA and Pompe Disease.

Contact Details

Address: 215 FIRST STREET SUITE 415
City: CAMBRIDGE
State: MA
Country: USA
Zip Code: 02142
Phone Number: 617-274-4000
Website: -

Financial Highlights

Day Range The price range a stock has traded at during the most recent trading period.: -

-
5 Day Range The price range a stock has traded at during the previous 5 days.: -

-
3 Month Range The price range a stock has traded at during the previous 3 months.: -

-
52 Week Range The price range a stock has traded at during the previous 52 weeks.: -

-
Previous Close The closing price of a stock from the previous day.: -
Open The price of the stock at the start of today’s market opening.: -
Bid The amount of money a trader is willing to pay per share for a given stock.: x
-
Ask The amount of money a seller wants per share of a given stock.: x
-
Volume The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.: -
Avg. Volume The average number of shares traded in a given day.: -
Dividend Yield A company's annual dividend expressed as a percentage of its current stock price.: -
Recent Dividend The value a shareholder receives from a company they are invested in for holding their shares.: -
Beta A measurement of the stock’s volatility in comparison to the market as a whole.: -

Shareholding

Shares Outstanding Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.: -
Insider Shareholders The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.: -
Institutional Shareholders The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.: -

Market Cap The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.: -
Revenue TTM The amount of money a company has made for the trailing twelve-month period.: -
Net Income TTM A measurement of how much profit they are retaining for the trailing twelve-month period.: -
P/E Ratio The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.: -
EPS TTM Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.: -
1 Year Return A measurement of how much the stock has increased or decreased in the last year.: -